Why Are Dysplastic Naevi And Suspicious Pigmented Skin Lesions Considered Absolute Contraindications For Cosmetic Laser And Ipl Procedures? Essential Safety Protocols For Clinics

Dysplastic naevi and suspicious pigmented lesions must not be treated cosmetically with laser or IPL because the energy can destroy or alter the tissue needed to diagnose skin cancer. If a lesion is melanoma or another malignancy, treatment may partially remove it, obscure its clinical features, and delay definitive medical care. A lesion that cannot be confidently diagnosed as benign requires dermatological assessment and, when indicated, biopsy before any cosmetic light-based procedure.

The central issue is diagnostic safety: laser and IPL can change or eliminate the tissue architecture required for histological examination. Treating an uncertain pigmented lesion risks missing melanoma, producing a misleading recurrent lesion, and delaying appropriate treatment.

Why Diagnosis Must Come First

Suspicious lesions may resemble benign pigmentation

Dysplastic naevi can have irregular colour, shape, or borders that overlap with the clinical features of melanoma. Other lesions, including lentigo maligna and early melanoma, may also appear to be ordinary cosmetic pigmentation.

Clinical inspection alone cannot always establish whether a lesion is benign. When malignancy cannot be confidently excluded, the lesion is medically diagnostic rather than cosmetic.

Laser and IPL are destructive treatments

Pigment-targeting lasers and IPL deliver optical energy that is absorbed by melanin and converted into heat. Depending on the device and settings, this can thermally damage, ablate, or destroy the lesion.

That damage is fundamentally different from a diagnostic biopsy, which preserves a representative tissue sample for microscopic examination.

Histological verification may become impossible

A biopsy allows a pathologist to examine the lesion’s architecture, cellular features, and relationship to surrounding skin. Laser or IPL treatment can remove or distort these structures before they are sampled.

This may make it difficult or impossible to determine whether the original lesion contained atypical or malignant cells. In practical terms, cosmetic treatment can eliminate the evidence needed to make the correct diagnosis.

How Treatment Can Delay Melanoma Detection

Partial treatment can leave malignant cells behind

Energy-based treatment may not remove every abnormal cell. Residual melanoma or another malignant process can continue beneath apparently improved skin.

Because the visible pigmentation may have faded, subsequent assessment can become more difficult and diagnosis may be delayed.

Healing can obscure important clinical features

Post-treatment inflammation, crusting, scarring, and changes in pigmentation can alter the lesion’s appearance. These changes may mask warning signs that would otherwise prompt urgent evaluation.

A later lesion may therefore be harder to compare with baseline photographs or assess using established clinical criteria.

Recurrent pigmentation can mimic melanoma

Pigment that returns within a scar or previously treated area may produce a pseudomelanoma, also called a recurrent naevus phenomenon. This can resemble melanoma clinically and microscopically.

The resulting uncertainty may require additional biopsies or excision, while the original lesion’s untreated appearance and diagnostic context have already been lost.

Why This Is an Absolute Contraindication

Cosmetic benefit does not justify diagnostic risk

Laser and IPL are elective treatments. Removing a pigmented lesion for cosmetic reasons is not justified when doing so could compromise cancer diagnosis.

The appropriate priority is to establish the lesion’s nature first, then consider cosmetic treatment only if a qualified clinician confirms that it is suitable.

The biological effects on dysplastic cells are uncertain

Dysplastic naevi contain atypical melanocytic features, and the long-term consequences of exposing them to cosmetic light-based energy are not sufficiently predictable for routine treatment. The principal established concern is not a proven cancer-causing effect, but the risk of altering, partially destroying, or obscuring a potentially malignant lesion.

That uncertainty reinforces the need for a strict contraindication.

A clear diagnosis is required before treatment

Before treating pigmented skin, the practitioner must distinguish a benign target, such as a solar lentigo or ephelis, from a lesion requiring medical investigation. If that distinction cannot be made reliably, treatment should be refused or deferred.

The lesion should be assessed by an appropriately qualified dermatologist, with histological examination when clinically indicated.

Understanding the Trade-offs

Treating first and biopsying later is the wrong sequence

A common mistake is to remove the visible pigment and plan to investigate only if it returns. This reverses the correct clinical order.

Diagnosis must precede destruction, because a later biopsy may no longer represent the original lesion accurately.

Dermoscopy does not eliminate every uncertainty

Dermoscopy and clinical photography can improve assessment and monitoring, but they do not replace histology when a lesion remains suspicious or diagnostically unclear. A reassuring visual assessment is not a licence to treat an uncertain lesion cosmetically.

“Benign-looking” is not the same as “diagnosed benign”

Some malignant lesions can initially appear subtle, and some dysplastic naevi may be difficult to classify confidently. The relevant threshold is not whether the lesion seems likely to be harmless, but whether malignancy has been adequately excluded.

The contraindication applies to both laser and IPL

Although laser systems use specific wavelengths and IPL uses a broader range of light, both can deliver energy absorbed by pigment and both can alter tissue. The diagnostic risk therefore applies to cosmetic treatment with either modality.

Making the Right Choice for Your Goal

A safe decision depends on the lesion’s diagnosis, not simply on its colour or cosmetic appearance.

If your primary focus is cosmetic pigment removal: Treat only lesions that have been clinically diagnosed as appropriate benign targets, and leave dysplastic or uncertain lesions untreated.
If your primary focus is cancer prevention: Arrange prompt dermatological assessment and biopsy when a lesion is suspicious, changing, or not confidently classifiable.
If your primary focus is practitioner safety: Document the pre-treatment examination, avoid treating questionable lesions, and refer them before using laser or IPL.
If your primary focus is monitoring: Photograph and assess the lesion before any intervention so that future changes can be evaluated against an intact baseline.

When a pigmented lesion is uncertain, preserving its diagnostic integrity is more important than achieving a cosmetic result.

Summary Table:

Reason	Explanation
Diagnostic integrity	Laser/IPL can destroy or alter tissue needed for biopsy, making histological diagnosis impossible.
Risk of incomplete removal	Malignant cells may remain, leading to delayed detection of melanoma.
Obscured clinical features	Post-treatment scarring and pigmentation changes can mask warning signs.
Recurrent pigmentation	Pseudomelanoma can mimic melanoma, complicating follow-up.
Uncertain biological effects	Long-term effects on dysplastic cells are unpredictable, reinforcing the contraindication.
Dermoscopy limitations	Visual assessment cannot replace histology for uncertain lesions.

Ensure safe, effective aesthetic treatments with BELIS. Our advanced laser and IPL systems are designed for clinics and premium salons, but patient safety comes first. Contact our experts today to implement rigorous screening protocols and choose the right device for your practice. Contact us now to discuss your needs and elevate your standards.